Pacira BioSciences, Inc. filed Post-Effective Amendments to thirteen Form S-8 registration statements on November 17, 2026, deregistering all previously unsold shares of common stock across those statements following the completion of its merger with Viatris Inc.
Key Highlights
- Merger completed November 17, 2026: Peach Purchaser Sub Inc., a wholly owned subsidiary of Viatris Inc., merged with and into Pacira BioSciences, with Pacira surviving as a wholly owned subsidiary of Viatris.
- Thirteen registration statements deregistered: Registration numbers spanning from 333-175101 (filed June 23, 2011) through 333-297971 (filed August 4, 2026) were terminated.
- All share offerings terminated: According to the filing, the registrant terminated all offerings and sales under all thirteen Registration Statements as a result of the merger.
- No remaining registered shares: The filing states that after giving effect to these Post-Effective Amendments, there will be no remaining shares registered by the company pursuant to the Registration Statements.
- Plans covered include multiple equity programs: The deregistered shares related to the Amended and Restated 2011 Stock Incentive Plan, the Amended and Restated 2014 Employee Stock Purchase Plan, and the Amended and Restated 2014 Inducement Plan, among others.
- Merger Agreement dated October 8, 2026: The filing identifies the Agreement and Plan of Merger as entered into among Pacira BioSciences, Viatris Inc., and Peach Purchaser Sub Inc. on that date.
Pacira BioSciences Closes Equity Plans as Viatris Merger Takes Effect
Pacira BioSciences, Inc., a Delaware corporation headquartered at 2000 Sierra Point Parkway, Suite 900, Brisbane, California, filed these Post-Effective Amendments with the SEC on November 17, 2026, in its capacity as the surviving entity following the merger with Viatris Inc. The company, which lists on NASDAQ:PCRX and carries the I.R.S. Employer Identification Number 51-0619477, had operated multiple equity compensation and employee stock purchase programs registered across thirteen separate Form S-8 statements filed between 2011 and 2026.
According to the filing, the merger was effected under the Agreement and Plan of Merger dated October 8, 2026, by and among Pacira BioSciences, Viatris Inc., and Peach Purchaser Sub Inc. Upon consummation, Peach Purchaser Sub Inc. merged with and into Pacira BioSciences, with Pacira surviving as a wholly owned subsidiary of Viatris. The filing states that as a result of the transactions contemplated by the Merger Agreement, the registrant terminated all offerings and sales pursuant to the thirteen Registration Statements.
The aggregate share counts registered across all thirteen statements were substantial. As individual examples, Registration Statement No. 333-212098, filed June 17, 2016, had registered 4,000,000 shares under the Amended and Restated 2011 Stock Incentive Plan, while Registration Statement No. 333-273613, filed August 2, 2023, had registered 3,300,000 shares under the same plan. The filing notes that the amendments remove from registration the shares registered but remaining unsold as of November 17, 2026, in accordance with undertakings the registrant had previously made within those Registration Statements. The Post-Effective Amendments were signed by Michael Rainerman, President of Pacira BioSciences, Inc.
What Was Disclosed
Pacira BioSciences filed Post-Effective Amendments to thirteen Form S-8 registration statements to deregister all unsold shares under its equity compensation plans, following the completion of its merger with Viatris Inc. on November 17, 2026, pursuant to a Merger Agreement dated October 8, 2026.





Please wait processing your request...